Total Payments
$1.0M
2024 Payments
$20,706
Companies
41
Transactions
1,242
Medicare Patients
536
Medicare Billing
$225,380
Payment Breakdown by Category
Other$777,069 (74.4%)
Travel$171,902 (16.5%)
Consulting$65,444 (6.3%)
Food & Beverage$26,345 (2.5%)
Education$3,404 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $422,294 | 166 | 40.4% |
| Honoraria | $184,708 | 67 | 17.7% |
| Travel and Lodging | $171,902 | 530 | 16.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $134,418 | 33 | 12.9% |
| Consulting Fee | $65,444 | 32 | 6.3% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $35,650 | 14 | 3.4% |
| Food and Beverage | $26,345 | 393 | 2.5% |
| Education | $3,404 | 7 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shionogi Inc | $157,577 | 133 | $0 (2024) |
| La Jolla Pharmaceutical Company | $122,910 | 85 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $115,095 | 103 | $0 (2023) |
| PORTOLA PHARMACEUTICALS, LLC | $113,854 | 133 | $0 (2020) |
| Melinta Therapeutics, LLC | $72,577 | 110 | $0 (2023) |
| Mallinckrodt LLC | $61,014 | 84 | $0 (2018) |
| AcelRx Pharmaceuticals, Inc. | $60,476 | 80 | $0 (2020) |
| Merck Sharp & Dohme LLC | $54,106 | 88 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $52,609 | 83 | $0 (2018) |
| The Medicines Company | $52,434 | 92 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20,706 | 12 | Shionogi Inc ($20,706) |
| 2023 | $95,104 | 76 | Shionogi Inc ($53,124) |
| 2022 | $126,179 | 112 | Shionogi Inc ($50,562) |
| 2021 | $88,201 | 74 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($30,031) |
| 2020 | $45,895 | 76 | AcelRx Pharmaceuticals, Inc. ($11,134) |
| 2019 | $221,239 | 264 | AcelRx Pharmaceuticals, Inc. ($49,341) |
| 2018 | $200,618 | 243 | La Jolla Pharmaceutical Company ($64,657) |
| 2017 | $246,221 | 385 | Mallinckrodt LLC ($58,410) |
All Payment Transactions
1,242 individual payment records from CMS Open Payments — Page 3 of 50
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/28/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $117.75 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/28/2023 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $112.08 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/28/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $56.20 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/28/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Infections and Infectious Diseases | ||||||
| 06/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Travel and Lodging | Cash or cash equivalent | $217.58 | General |
| Category: Gastroenterology | ||||||
| 06/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $9.07 | General |
| Category: Gastroenterology | ||||||
| 05/25/2023 | Shionogi Inc | Fetroja (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,075.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/25/2023 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $1,096.71 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/25/2023 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $346.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/25/2023 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $250.11 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/25/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $103.56 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/24/2023 | Shionogi Inc | Fetroja (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $6,075.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/24/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $5,760.00 | General |
| Category: Gastroenterology | ||||||
| 05/24/2023 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $1,096.72 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/24/2023 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $346.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/24/2023 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $97.85 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/24/2023 | Shionogi Inc | Fetroja (Drug) | Travel and Lodging | Cash or cash equivalent | $22.70 | General |
| Category: Infections and Infectious Diseases | ||||||
| 05/23/2023 | Melinta Therapeutics, LLC | Vabomere (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: ANTIBIOTICS | ||||||
| 05/23/2023 | Melinta Therapeutics, LLC | Vabomere (Drug) | Travel and Lodging | Cash or cash equivalent | $459.21 | General |
| Category: ANTIBIOTICS | ||||||
| 05/23/2023 | Melinta Therapeutics, LLC | Vabomere (Drug) | Food and Beverage | In-kind items and services | $78.13 | General |
| Category: ANTIBIOTICS | ||||||
| 05/23/2023 | Melinta Therapeutics, LLC | Vabomere (Drug) | Travel and Lodging | Cash or cash equivalent | $40.00 | General |
| Category: ANTIBIOTICS | ||||||
| 05/18/2023 | Bioventus LLC | SonicOne Clinic (Device) | Food and Beverage | In-kind items and services | $186.62 | General |
| Category: Devices | ||||||
| 05/17/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Travel and Lodging | Cash or cash equivalent | $509.80 | General |
| Category: Gastroenterology | ||||||
| 05/17/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $115.45 | General |
| Category: Gastroenterology | ||||||
| 05/08/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $3,255.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 114 | 383 | $207,685 | $47,028 |
| 2022 | 6 | 134 | 413 | $222,705 | $49,743 |
| 2021 | 5 | 133 | 402 | $243,690 | $53,539 |
| 2020 | 6 | 155 | 580 | $327,600 | $75,069 |
Total Patients
536
Total Services
1,778
Medicare Billing
$225,380
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 41 | 216 | $159,840 | $34,970 | 21.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 112 | $31,360 | $9,854 | 31.4% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 16 | 20 | $12,600 | $1,287 | 10.2% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 18 | 23 | $3,105 | $786.14 | 25.3% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 11 | 12 | $780.00 | $131.04 | 16.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 40 | 226 | $167,240 | $37,831 | 22.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 32 | 75 | $21,000 | $5,729 | 27.3% |
| 99183 | Management of oxygen chamber therapy | Facility | 2022 | 11 | 48 | $15,840 | $3,750 | 23.7% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 18 | 23 | $14,490 | $1,500 | 10.4% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 17 | 21 | $2,835 | $721.35 | 25.4% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 16 | 20 | $1,300 | $211.26 | 16.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 58 | 278 | $205,720 | $46,089 | 22.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 24 | 61 | $17,080 | $4,839 | 28.3% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 19 | 27 | $17,010 | $1,717 | 10.1% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2021 | 20 | 22 | $2,970 | $749.80 | 25.2% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2021 | 12 | 14 | $910.00 | $143.92 | 15.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 50 | 333 | $246,420 | $58,240 | 23.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 26 | 116 | $38,000 | $9,465 | 24.9% |
| 99183 | Management and supervision of oxygen chamber therapy per session | Facility | 2020 | 14 | 40 | $13,200 | $3,370 | 25.5% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 26 | 39 | $24,570 | $2,685 | 10.9% |
| 36620 | Insertion of arterial catheter for blood sampling or infusion, accessed through the skin | Facility | 2020 | 20 | 29 | $3,915 | $1,047 | 26.7% |
| 76937 | Ultrasound guidance for accessing into blood vessel | Facility | 2020 | 19 | 23 | $1,495 | $263.12 | 17.6% |
About Dr. Bruce Friedman, M.D
Dr. Bruce Friedman, M.D is a Critical Care Medicine healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1417939315.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Friedman, M.D has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $20,706 received in 2024. These payments were reported across 1,242 transactions from 41 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($422,294).
As a Medicare-enrolled provider, Friedman has provided services to 536 Medicare beneficiaries, totaling 1,778 services with total Medicare billing of $225,380. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Internal Medicine
- Location Augusta, GA
- Active Since 11/16/2005
- Last Updated 10/03/2011
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1417939315
Products in Payments
- Fetroja (Drug) $143,476
- RELISTOR (Drug) $108,542
- GIAPREZA (Drug) $107,098
- OFIRMEV (Drug) $61,014
- DSUVIA (Drug) $60,476
- ANDEXXA (Biological) $59,343
- BEVYXXA (Drug) $55,028
- Xtampza ER (Drug) $52,609
- NUZYRA (Drug) $46,678
- ZERBAXA (Drug) $45,070
- VIBATIV (Drug) $36,801
- Baxdela (Drug) $34,026
- Vabomere (Drug) $30,920
- MINOCIN IV (Drug) $30,273
- XERAVA (Drug) $15,621
- CRESEMBA (Drug) $15,581
- VABOMERE (Drug) $14,216
- Dermatology and Wound Care (Medical Supply) $13,671
- Xerava (Drug) $11,215
- AVYCAZ (Drug) $9,350
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Augusta
Dr. Carmel Joseph, Md, MD
Critical Care Medicine — Payments: $44,125
Critical Care Medicine $44,125
Shaheen Islam, Mbbs, MBBS
Critical Care Medicine — Payments: $21,874
Critical Care Medicine $21,874
Dr. Varsha Kulkarni, M.d, M.D
Critical Care Medicine — Payments: $14,293
Critical Care Medicine $14,293
Dr. Scott Pethke, M.d, M.D
Critical Care Medicine — Payments: $14,046
Critical Care Medicine $14,046
Brent Bermingham, Md, MD
Critical Care Medicine — Payments: $5,374
Critical Care Medicine $5,374
Dr. Anthony Ramage, Do, DO
Critical Care Medicine — Payments: $2,621
Critical Care Medicine $2,621